Utilizing the presence of a biomarker when determining which targeted therapy is appropriate for a patient is known as
ONS / ONCC Chemotherapy Immunotherapy Certificate Initial Course Post Test Question 6 of 60 Utilizing the presence of a biomarker when determining which targeted therapy is appropriate for a patient is known as: A. chemoprevention.B. immunosuppression.C. precision oncology.D. non-myeloablative therapy. The Correct Answer and Explanation is: Correct Answer: C. Precision oncology Explanation: Precision oncology is […]